RxSight Inc Forecast, price target & analysts
RxSight Inc Target price 2025 - Analyst rating & recommendation
RxSight Inc Classifications & Recommendation:
RxSight Inc Price Target
| Target Price | $10.20 |
| Price | $11.46 |
| Deviation |
10.99%
register free of charge
|
| Number of Estimates | 11 |
|
11 Analysts have issued a price target RxSight Inc 2026 .
The average RxSight Inc target price is $10.20.
This is
10.99%
register free of charge
$12.60
9.95%
register free of charge
$8.08
29.49%
register free of charge
|
|
| A rating was issued by 16 analysts: 1 Analysts recommend RxSight Inc to buy, 10 to hold and 5 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the RxSight Inc stock has an average upside potential 2026 of
10.99%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 139.93 | 131.80 |
| 57.08% | 5.81% | |
| EBITDA Margin | -26.31% | -35.36% |
| 53.07% | 34.42% | |
| Net Margin | -19.62% | -33.89% |
| 64.04% | 72.70% |
13 Analysts have issued a sales forecast RxSight Inc 2025 . The average RxSight Inc sales estimate is
This results in the following potential growth metrics:
11 Analysts have issued an RxSight Inc EBITDA forecast 2025. The average RxSight Inc EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 RxSight Inc Analysts have issued a net profit forecast 2025. The average RxSight Inc net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2028
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.71 | -1.09 |
| 49.65% | 53.52% | |
| P/E | negative | |
| EV/Sales | 1.85 |
13 Analysts have issued a RxSight Inc forecast for earnings per share. The average RxSight Inc EPS is
This results in the following potential growth metrics and future valuations:
Current RxSight Inc Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Morgan Stanley |
Locked
➜
Locked
|
Locked | Dec 02 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| Wells Fargo |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| JP Morgan |
Locked
➜
Locked
|
Locked | Nov 06 2025 |
| Needham |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| UBS |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Stifel |
Locked
➜
Locked
|
Locked | Aug 08 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Morgan Stanley:
Locked
➜
Locked
|
Dec 02 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
Wells Fargo:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
JP Morgan:
Locked
➜
Locked
|
Nov 06 2025 |
|
Locked
Needham:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
UBS:
Locked
➜
Locked
|
Aug 08 2025 |
|
Locked
Stifel:
Locked
➜
Locked
|
Aug 08 2025 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
